The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hypomethylating agent (HMA) therapy use and survival in older patients with higher risk myelodysplastic syndromes (HR-MDS) in the United States (USA): A large population-based study.
 
Amer M Zeidan
Consulting or Advisory Role - ARIAD; Celgene; Gilead Sciences; Incyte; Pfizer
Speakers' Bureau - ARIAD
 
Xin Hu
No Relationships to Disclose
 
Jessica B. Long
No Relationships to Disclose
 
Rong Wang
No Relationships to Disclose
 
Scott F. Huntington
Honoraria - Pharmacyclics
Consulting or Advisory Role - Celgene; Janssen
Travel, Accommodations, Expenses - Celgene
 
Nikolai Alexandrovich Podoltsev
Consulting or Advisory Role - Alexion Pharmaceuticals; CTI
Research Funding - Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Celator (Inst); Daiichi Sankyo (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst)
 
Smith Giri
No Relationships to Disclose
 
Maximilian Stahl
No Relationships to Disclose
 
Steven Gore
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene
 
Xiaomei Ma
Consulting or Advisory Role - Celgene
 
Amy J. Davidoff
Honoraria - Celgene (I)
Consulting or Advisory Role - Celgene (I)
Research Funding - Boehringer Ingelheim (I); Celgene (I)
Travel, Accommodations, Expenses - Celgene (I)
Other Relationship - PhRMA Foundation